What is the current market size for the nanomedicine market?

The worldwide nanomedicine market grew rapidly in 2023, reaching a significant valuation of USD 174.13 billion. By 2030, this impressive number is anticipated to reach a valuation of USD 374.72 billion growing at a remarkable CAGR of 11.57% during the forecast period, 2024-2030.

What are the market drivers for nanomedicines?

The potential pipeline of nano compounds and related technologies, technical breakthroughs, and advances in nanorobotics are the main drivers of the growth of the nanomedicine industry.

Which indication-based market segments are the most important ones in nanomedicine?

The indications of neurological disorders, orthopaedic illnesses, cardiovascular diseases, infectious diseases, oncology, and other medical issues are used to segment the nanomedicine market.

Why is oncology thought to be a key area for nanomedicine growth?

The remarkable 11.5% growth in oncology from 2024 to 2030 is a result of the global increase in cancer incidence. The cutting-edge approach of nanomedicine targets cancer cells directly, minimising side effects and revolutionising cancer therapy.

What aspects of oncology make nanomedicine so popular?

The capacity of nanomedicine to solve shortcomings in conventional cancer treatments, developments in nanotechnology, and rising research funding are what are fueling the field's expansion in oncology. It makes a name for itself by revolutionising cancer treatment with focused and practical solutions.

Nanomedicine Market | Size, Share, Growth

Nanomedicine Market Research Report – Segmented By Molecule Type (Nanoparticles, Nanoshells, Nanotubes, Nanodevices ), Application (Vaccines, Regenerative Medicines, Diagnostic Imaging, Drug Delivery, Implants, In-Vitro Imaging, In-Vitro Diagnostics, Therapeutics, Others), Indication (Oncological Diseases, Infectious Diseases, Cardiovascular Diseases, Orthopaedic Disorders, Neurological Disorders, Urological Disorders, Ophthalmological Diseases, Immunological Diseases, Anti-Inflammatory Diseases, Anti-Infective Diseases, Others) and Modality(Treatment, Diagnostics), Service Provider (Private and Public); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)

Published: 2024 - Jan

Report Code: VMR-2905

Region: Global

Historic Range: 2021-2023

Forecast: 2024-2030

Format: Excel and PDF

👨‍💼 Ask an Expert

Fill out the form below and our team will get back to you shortly

The field with (*) is required.

📋 Contact Information

Name *

Email *

Company *

Job Title *

Country *

Phone *

Message (Optional)

Security Verification

This form is protected by Google reCAPTCHA v3. Verification runs automatically when you submit.

Your information is secure and will not be shared with third parties.

Select User License Type

Data Spreadsheet: Market data delivered in spreadsheet format for analysis.

Single User: One named user; PDF report access for internal use.

Multi User: Up to five users within the same organization at one location.

Corporate User: Enterprise-wide access across your organization.

Data Spreadsheet

2500

Single User

4250

Multi User

5250

Corporate User

6900

Country-Specific Report

Dive into Country Outlook

Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.

Access Country Insights

Testimonials

“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”

Medical Devices Company based in Europe